NATALIE BERNYS: Open Payments
NPI 1104159425 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 83 payments from 19 companies in 2025. Trend: 2023 $1,560 · 2024 $1,330 · 2025 $1,707
Food & beverage: $1,707
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $418 |
| PFIZER INC. | 16 | $327 |
| ABBVIE INC. | 13 | $213 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Lilly USA, LLC | 8 | $129 |
| Optinose US, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: Wegovy, NURTEC ODT, Ozempic, QULIPTA, FARXIGA, Xhance, BREZTRI, KISUNLA.
Industry payments across VA — which companies pay providers there.
